nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—Rivastigmine—Alzheimer's disease	0.194	0.432	CbGbCtD
Salbutamol—CYP3A4—Donepezil—Alzheimer's disease	0.155	0.345	CbGbCtD
Salbutamol—CYP3A4—Galantamine—Alzheimer's disease	0.1	0.223	CbGbCtD
Salbutamol—Clenbuterol—NGF—Alzheimer's disease	0.00673	0.605	CrCbGaD
Salbutamol—Terbutaline—BCHE—Alzheimer's disease	0.00168	0.151	CrCbGaD
Salbutamol—Clenbuterol—TNF—Alzheimer's disease	0.0013	0.117	CrCbGaD
Salbutamol—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000859	0.00172	CcSEcCtD
Salbutamol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000859	0.00172	CcSEcCtD
Salbutamol—Carteolol—CYP2D6—Alzheimer's disease	0.000858	0.0771	CrCbGaD
Salbutamol—Myalgia—Galantamine—Alzheimer's disease	0.000854	0.00171	CcSEcCtD
Salbutamol—Arthralgia—Galantamine—Alzheimer's disease	0.000854	0.00171	CcSEcCtD
Salbutamol—Chest pain—Galantamine—Alzheimer's disease	0.000854	0.00171	CcSEcCtD
Salbutamol—Epistaxis—Memantine—Alzheimer's disease	0.000852	0.00171	CcSEcCtD
Salbutamol—Anxiety—Galantamine—Alzheimer's disease	0.000851	0.0017	CcSEcCtD
Salbutamol—Sinusitis—Memantine—Alzheimer's disease	0.000847	0.0017	CcSEcCtD
Salbutamol—Sweating—Rivastigmine—Alzheimer's disease	0.000847	0.0017	CcSEcCtD
Salbutamol—Discomfort—Galantamine—Alzheimer's disease	0.000844	0.00169	CcSEcCtD
Salbutamol—Haematuria—Rivastigmine—Alzheimer's disease	0.000842	0.00169	CcSEcCtD
Salbutamol—Dry mouth—Galantamine—Alzheimer's disease	0.000835	0.00167	CcSEcCtD
Salbutamol—Epistaxis—Rivastigmine—Alzheimer's disease	0.000833	0.00167	CcSEcCtD
Salbutamol—Tinnitus—Donepezil—Alzheimer's disease	0.000833	0.00167	CcSEcCtD
Salbutamol—Sinusitis—Rivastigmine—Alzheimer's disease	0.000829	0.00166	CcSEcCtD
Salbutamol—Haemoglobin—Memantine—Alzheimer's disease	0.000815	0.00163	CcSEcCtD
Salbutamol—Rhinitis—Memantine—Alzheimer's disease	0.000813	0.00163	CcSEcCtD
Salbutamol—Haemorrhage—Memantine—Alzheimer's disease	0.000811	0.00162	CcSEcCtD
Salbutamol—Hypoaesthesia—Memantine—Alzheimer's disease	0.000807	0.00162	CcSEcCtD
Salbutamol—Shock—Galantamine—Alzheimer's disease	0.000805	0.00161	CcSEcCtD
Salbutamol—Pharyngitis—Memantine—Alzheimer's disease	0.000805	0.00161	CcSEcCtD
Salbutamol—Nervous system disorder—Galantamine—Alzheimer's disease	0.000803	0.00161	CcSEcCtD
Salbutamol—Chills—Donepezil—Alzheimer's disease	0.000801	0.0016	CcSEcCtD
Salbutamol—Urinary tract disorder—Memantine—Alzheimer's disease	0.000801	0.0016	CcSEcCtD
Salbutamol—Tachycardia—Galantamine—Alzheimer's disease	0.000799	0.0016	CcSEcCtD
Salbutamol—Arrhythmia—Donepezil—Alzheimer's disease	0.000798	0.0016	CcSEcCtD
Salbutamol—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000797	0.0016	CcSEcCtD
Salbutamol—Connective tissue disorder—Memantine—Alzheimer's disease	0.000797	0.0016	CcSEcCtD
Salbutamol—Rhinitis—Rivastigmine—Alzheimer's disease	0.000795	0.00159	CcSEcCtD
Salbutamol—Skin disorder—Galantamine—Alzheimer's disease	0.000795	0.00159	CcSEcCtD
Salbutamol—Urethral disorder—Memantine—Alzheimer's disease	0.000795	0.00159	CcSEcCtD
Salbutamol—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000793	0.00159	CcSEcCtD
Salbutamol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000791	0.00158	CcSEcCtD
Salbutamol—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000789	0.00158	CcSEcCtD
Salbutamol—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000787	0.00158	CcSEcCtD
Salbutamol—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000783	0.00157	CcSEcCtD
Salbutamol—Mental disorder—Donepezil—Alzheimer's disease	0.000782	0.00157	CcSEcCtD
Salbutamol—Anorexia—Galantamine—Alzheimer's disease	0.00078	0.00156	CcSEcCtD
Salbutamol—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000779	0.00156	CcSEcCtD
Salbutamol—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000777	0.00156	CcSEcCtD
Salbutamol—Malnutrition—Donepezil—Alzheimer's disease	0.000777	0.00156	CcSEcCtD
Salbutamol—Flatulence—Donepezil—Alzheimer's disease	0.000766	0.00153	CcSEcCtD
Salbutamol—Hypotension—Galantamine—Alzheimer's disease	0.000765	0.00153	CcSEcCtD
Salbutamol—Tension—Donepezil—Alzheimer's disease	0.000763	0.00153	CcSEcCtD
Salbutamol—Dysgeusia—Donepezil—Alzheimer's disease	0.000761	0.00152	CcSEcCtD
Salbutamol—Tinnitus—Memantine—Alzheimer's disease	0.000756	0.00151	CcSEcCtD
Salbutamol—Nervousness—Donepezil—Alzheimer's disease	0.000755	0.00151	CcSEcCtD
Salbutamol—Flushing—Memantine—Alzheimer's disease	0.000752	0.00151	CcSEcCtD
Salbutamol—Cardiac disorder—Memantine—Alzheimer's disease	0.000752	0.00151	CcSEcCtD
Salbutamol—Back pain—Donepezil—Alzheimer's disease	0.000752	0.00151	CcSEcCtD
Salbutamol—Muscle spasms—Donepezil—Alzheimer's disease	0.000747	0.0015	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000746	0.00149	CcSEcCtD
Salbutamol—Insomnia—Galantamine—Alzheimer's disease	0.00074	0.00148	CcSEcCtD
Salbutamol—Tinnitus—Rivastigmine—Alzheimer's disease	0.000739	0.00148	CcSEcCtD
Salbutamol—Flushing—Rivastigmine—Alzheimer's disease	0.000736	0.00147	CcSEcCtD
Salbutamol—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000736	0.00147	CcSEcCtD
Salbutamol—Angiopathy—Memantine—Alzheimer's disease	0.000736	0.00147	CcSEcCtD
Salbutamol—Paraesthesia—Galantamine—Alzheimer's disease	0.000735	0.00147	CcSEcCtD
Salbutamol—Immune system disorder—Memantine—Alzheimer's disease	0.000732	0.00147	CcSEcCtD
Salbutamol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000731	0.00146	CcSEcCtD
Salbutamol—Tremor—Donepezil—Alzheimer's disease	0.000728	0.00146	CcSEcCtD
Salbutamol—Somnolence—Galantamine—Alzheimer's disease	0.000728	0.00146	CcSEcCtD
Salbutamol—Chills—Memantine—Alzheimer's disease	0.000727	0.00146	CcSEcCtD
Salbutamol—Arrhythmia—Memantine—Alzheimer's disease	0.000724	0.00145	CcSEcCtD
Salbutamol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000721	0.00144	CcSEcCtD
Salbutamol—Dyspepsia—Galantamine—Alzheimer's disease	0.000721	0.00144	CcSEcCtD
Salbutamol—Angiopathy—Rivastigmine—Alzheimer's disease	0.00072	0.00144	CcSEcCtD
Salbutamol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000715	0.00143	CcSEcCtD
Salbutamol—Agitation—Donepezil—Alzheimer's disease	0.000714	0.00143	CcSEcCtD
Salbutamol—Chills—Rivastigmine—Alzheimer's disease	0.000712	0.00143	CcSEcCtD
Salbutamol—Decreased appetite—Galantamine—Alzheimer's disease	0.000712	0.00142	CcSEcCtD
Salbutamol—Mental disorder—Memantine—Alzheimer's disease	0.00071	0.00142	CcSEcCtD
Salbutamol—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000709	0.00142	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000707	0.00142	CcSEcCtD
Salbutamol—Malnutrition—Memantine—Alzheimer's disease	0.000706	0.00141	CcSEcCtD
Salbutamol—Fatigue—Galantamine—Alzheimer's disease	0.000706	0.00141	CcSEcCtD
Salbutamol—Malaise—Donepezil—Alzheimer's disease	0.000701	0.0014	CcSEcCtD
Salbutamol—Constipation—Galantamine—Alzheimer's disease	0.0007	0.0014	CcSEcCtD
Salbutamol—Vertigo—Donepezil—Alzheimer's disease	0.000698	0.0014	CcSEcCtD
Salbutamol—Syncope—Donepezil—Alzheimer's disease	0.000697	0.0014	CcSEcCtD
Salbutamol—Flatulence—Memantine—Alzheimer's disease	0.000695	0.00139	CcSEcCtD
Salbutamol—Mental disorder—Rivastigmine—Alzheimer's disease	0.000695	0.00139	CcSEcCtD
Salbutamol—Tension—Memantine—Alzheimer's disease	0.000693	0.00139	CcSEcCtD
Salbutamol—Dysgeusia—Memantine—Alzheimer's disease	0.000691	0.00138	CcSEcCtD
Salbutamol—Malnutrition—Rivastigmine—Alzheimer's disease	0.00069	0.00138	CcSEcCtD
Salbutamol—Nervousness—Memantine—Alzheimer's disease	0.000685	0.00137	CcSEcCtD
Salbutamol—Loss of consciousness—Donepezil—Alzheimer's disease	0.000683	0.00137	CcSEcCtD
Salbutamol—Back pain—Memantine—Alzheimer's disease	0.000683	0.00137	CcSEcCtD
Salbutamol—Flatulence—Rivastigmine—Alzheimer's disease	0.00068	0.00136	CcSEcCtD
Salbutamol—Cough—Donepezil—Alzheimer's disease	0.000678	0.00136	CcSEcCtD
Salbutamol—Tension—Rivastigmine—Alzheimer's disease	0.000678	0.00136	CcSEcCtD
Salbutamol—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000676	0.00135	CcSEcCtD
Salbutamol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000675	0.00135	CcSEcCtD
Salbutamol—Hypertension—Donepezil—Alzheimer's disease	0.000671	0.00134	CcSEcCtD
Salbutamol—Nervousness—Rivastigmine—Alzheimer's disease	0.000671	0.00134	CcSEcCtD
Salbutamol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000669	0.00134	CcSEcCtD
Salbutamol—Back pain—Rivastigmine—Alzheimer's disease	0.000668	0.00134	CcSEcCtD
Salbutamol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000664	0.00133	CcSEcCtD
Salbutamol—Chest pain—Donepezil—Alzheimer's disease	0.000662	0.00133	CcSEcCtD
Salbutamol—Arthralgia—Donepezil—Alzheimer's disease	0.000662	0.00133	CcSEcCtD
Salbutamol—Myalgia—Donepezil—Alzheimer's disease	0.000662	0.00133	CcSEcCtD
Salbutamol—Tremor—Memantine—Alzheimer's disease	0.000661	0.00132	CcSEcCtD
Salbutamol—Anxiety—Donepezil—Alzheimer's disease	0.000659	0.00132	CcSEcCtD
Salbutamol—Ill-defined disorder—Memantine—Alzheimer's disease	0.000655	0.00131	CcSEcCtD
Salbutamol—Discomfort—Donepezil—Alzheimer's disease	0.000654	0.00131	CcSEcCtD
Salbutamol—Agitation—Memantine—Alzheimer's disease	0.000649	0.0013	CcSEcCtD
Salbutamol—Dry mouth—Donepezil—Alzheimer's disease	0.000647	0.0013	CcSEcCtD
Salbutamol—Abdominal pain—Galantamine—Alzheimer's disease	0.000647	0.0013	CcSEcCtD
Salbutamol—Body temperature increased—Galantamine—Alzheimer's disease	0.000647	0.0013	CcSEcCtD
Salbutamol—Tremor—Rivastigmine—Alzheimer's disease	0.000647	0.0013	CcSEcCtD
Salbutamol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000641	0.00128	CcSEcCtD
Salbutamol—Malaise—Memantine—Alzheimer's disease	0.000636	0.00127	CcSEcCtD
Salbutamol—Agitation—Rivastigmine—Alzheimer's disease	0.000634	0.00127	CcSEcCtD
Salbutamol—Oedema—Donepezil—Alzheimer's disease	0.000634	0.00127	CcSEcCtD
Salbutamol—Vertigo—Memantine—Alzheimer's disease	0.000634	0.00127	CcSEcCtD
Salbutamol—Syncope—Memantine—Alzheimer's disease	0.000633	0.00127	CcSEcCtD
Salbutamol—Infection—Donepezil—Alzheimer's disease	0.00063	0.00126	CcSEcCtD
Salbutamol—Shock—Donepezil—Alzheimer's disease	0.000624	0.00125	CcSEcCtD
Salbutamol—Palpitations—Memantine—Alzheimer's disease	0.000624	0.00125	CcSEcCtD
Salbutamol—Malaise—Rivastigmine—Alzheimer's disease	0.000623	0.00125	CcSEcCtD
Salbutamol—Nervous system disorder—Donepezil—Alzheimer's disease	0.000622	0.00125	CcSEcCtD
Salbutamol—Vertigo—Rivastigmine—Alzheimer's disease	0.00062	0.00124	CcSEcCtD
Salbutamol—Loss of consciousness—Memantine—Alzheimer's disease	0.00062	0.00124	CcSEcCtD
Salbutamol—Syncope—Rivastigmine—Alzheimer's disease	0.000619	0.00124	CcSEcCtD
Salbutamol—Cough—Memantine—Alzheimer's disease	0.000616	0.00123	CcSEcCtD
Salbutamol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000613	0.00123	CcSEcCtD
Salbutamol—Palpitations—Rivastigmine—Alzheimer's disease	0.00061	0.00122	CcSEcCtD
Salbutamol—Hypertension—Memantine—Alzheimer's disease	0.000609	0.00122	CcSEcCtD
Salbutamol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000607	0.00122	CcSEcCtD
Salbutamol—Anorexia—Donepezil—Alzheimer's disease	0.000605	0.00121	CcSEcCtD
Salbutamol—Hypersensitivity—Galantamine—Alzheimer's disease	0.000603	0.00121	CcSEcCtD
Salbutamol—Cough—Rivastigmine—Alzheimer's disease	0.000602	0.00121	CcSEcCtD
Salbutamol—Chest pain—Memantine—Alzheimer's disease	0.000601	0.0012	CcSEcCtD
Salbutamol—Myalgia—Memantine—Alzheimer's disease	0.000601	0.0012	CcSEcCtD
Salbutamol—Arthralgia—Memantine—Alzheimer's disease	0.000601	0.0012	CcSEcCtD
Salbutamol—Anxiety—Memantine—Alzheimer's disease	0.000599	0.0012	CcSEcCtD
Salbutamol—Hypertension—Rivastigmine—Alzheimer's disease	0.000596	0.00119	CcSEcCtD
Salbutamol—Discomfort—Memantine—Alzheimer's disease	0.000594	0.00119	CcSEcCtD
Salbutamol—Hypotension—Donepezil—Alzheimer's disease	0.000593	0.00119	CcSEcCtD
Salbutamol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000588	0.00118	CcSEcCtD
Salbutamol—Myalgia—Rivastigmine—Alzheimer's disease	0.000588	0.00118	CcSEcCtD
Salbutamol—Chest pain—Rivastigmine—Alzheimer's disease	0.000588	0.00118	CcSEcCtD
Salbutamol—Dry mouth—Memantine—Alzheimer's disease	0.000588	0.00118	CcSEcCtD
Salbutamol—Asthenia—Galantamine—Alzheimer's disease	0.000587	0.00118	CcSEcCtD
Salbutamol—Anxiety—Rivastigmine—Alzheimer's disease	0.000586	0.00117	CcSEcCtD
Salbutamol—Discomfort—Rivastigmine—Alzheimer's disease	0.000581	0.00116	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000578	0.00116	CcSEcCtD
Salbutamol—Oedema—Memantine—Alzheimer's disease	0.000576	0.00115	CcSEcCtD
Salbutamol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000575	0.00115	CcSEcCtD
Salbutamol—Insomnia—Donepezil—Alzheimer's disease	0.000574	0.00115	CcSEcCtD
Salbutamol—Infection—Memantine—Alzheimer's disease	0.000572	0.00115	CcSEcCtD
Salbutamol—Paraesthesia—Donepezil—Alzheimer's disease	0.00057	0.00114	CcSEcCtD
Salbutamol—Shock—Memantine—Alzheimer's disease	0.000567	0.00113	CcSEcCtD
Salbutamol—Dyspnoea—Donepezil—Alzheimer's disease	0.000566	0.00113	CcSEcCtD
Salbutamol—Nervous system disorder—Memantine—Alzheimer's disease	0.000565	0.00113	CcSEcCtD
Salbutamol—Somnolence—Donepezil—Alzheimer's disease	0.000564	0.00113	CcSEcCtD
Salbutamol—Oedema—Rivastigmine—Alzheimer's disease	0.000563	0.00113	CcSEcCtD
Salbutamol—Tachycardia—Memantine—Alzheimer's disease	0.000562	0.00113	CcSEcCtD
Salbutamol—Diarrhoea—Galantamine—Alzheimer's disease	0.00056	0.00112	CcSEcCtD
Salbutamol—Infection—Rivastigmine—Alzheimer's disease	0.00056	0.00112	CcSEcCtD
Salbutamol—Skin disorder—Memantine—Alzheimer's disease	0.000559	0.00112	CcSEcCtD
Salbutamol—Dyspepsia—Donepezil—Alzheimer's disease	0.000558	0.00112	CcSEcCtD
Salbutamol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000557	0.00112	CcSEcCtD
Salbutamol—Shock—Rivastigmine—Alzheimer's disease	0.000554	0.00111	CcSEcCtD
Salbutamol—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000553	0.00111	CcSEcCtD
Salbutamol—Decreased appetite—Donepezil—Alzheimer's disease	0.000551	0.0011	CcSEcCtD
Salbutamol—Tachycardia—Rivastigmine—Alzheimer's disease	0.00055	0.0011	CcSEcCtD
Salbutamol—Anorexia—Memantine—Alzheimer's disease	0.000549	0.0011	CcSEcCtD
Salbutamol—Epinephrine—TNF—Alzheimer's disease	0.000548	0.0493	CrCbGaD
Salbutamol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000548	0.0011	CcSEcCtD
Salbutamol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000547	0.0011	CcSEcCtD
Salbutamol—Fatigue—Donepezil—Alzheimer's disease	0.000547	0.0011	CcSEcCtD
Salbutamol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000545	0.00109	CcSEcCtD
Salbutamol—Pain—Donepezil—Alzheimer's disease	0.000542	0.00109	CcSEcCtD
Salbutamol—Constipation—Donepezil—Alzheimer's disease	0.000542	0.00109	CcSEcCtD
Salbutamol—Dizziness—Galantamine—Alzheimer's disease	0.000541	0.00108	CcSEcCtD
Salbutamol—Hypotension—Memantine—Alzheimer's disease	0.000538	0.00108	CcSEcCtD
Salbutamol—Anorexia—Rivastigmine—Alzheimer's disease	0.000537	0.00108	CcSEcCtD
Salbutamol—Hypotension—Rivastigmine—Alzheimer's disease	0.000527	0.00105	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000525	0.00105	CcSEcCtD
Salbutamol—Feeling abnormal—Donepezil—Alzheimer's disease	0.000523	0.00105	CcSEcCtD
Salbutamol—Insomnia—Memantine—Alzheimer's disease	0.000521	0.00104	CcSEcCtD
Salbutamol—Vomiting—Galantamine—Alzheimer's disease	0.00052	0.00104	CcSEcCtD
Salbutamol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000519	0.00104	CcSEcCtD
Salbutamol—Paraesthesia—Memantine—Alzheimer's disease	0.000517	0.00104	CcSEcCtD
Salbutamol—Rash—Galantamine—Alzheimer's disease	0.000516	0.00103	CcSEcCtD
Salbutamol—Dermatitis—Galantamine—Alzheimer's disease	0.000516	0.00103	CcSEcCtD
Salbutamol—Dyspnoea—Memantine—Alzheimer's disease	0.000514	0.00103	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000513	0.00103	CcSEcCtD
Salbutamol—Headache—Galantamine—Alzheimer's disease	0.000513	0.00103	CcSEcCtD
Salbutamol—Somnolence—Memantine—Alzheimer's disease	0.000512	0.00103	CcSEcCtD
Salbutamol—Insomnia—Rivastigmine—Alzheimer's disease	0.00051	0.00102	CcSEcCtD
Salbutamol—Dyspepsia—Memantine—Alzheimer's disease	0.000507	0.00102	CcSEcCtD
Salbutamol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000506	0.00101	CcSEcCtD
Salbutamol—Urticaria—Donepezil—Alzheimer's disease	0.000504	0.00101	CcSEcCtD
Salbutamol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000502	0.00101	CcSEcCtD
Salbutamol—Body temperature increased—Donepezil—Alzheimer's disease	0.000501	0.001	CcSEcCtD
Salbutamol—Abdominal pain—Donepezil—Alzheimer's disease	0.000501	0.001	CcSEcCtD
Salbutamol—Somnolence—Rivastigmine—Alzheimer's disease	0.000501	0.001	CcSEcCtD
Salbutamol—Decreased appetite—Memantine—Alzheimer's disease	0.000501	0.001	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000497	0.000996	CcSEcCtD
Salbutamol—Fatigue—Memantine—Alzheimer's disease	0.000497	0.000994	CcSEcCtD
Salbutamol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000496	0.000993	CcSEcCtD
Salbutamol—Pain—Memantine—Alzheimer's disease	0.000493	0.000986	CcSEcCtD
Salbutamol—Constipation—Memantine—Alzheimer's disease	0.000493	0.000986	CcSEcCtD
Salbutamol—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00049	0.000981	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000486	0.000974	CcSEcCtD
Salbutamol—Nausea—Galantamine—Alzheimer's disease	0.000486	0.000974	CcSEcCtD
Salbutamol—Fatigue—Rivastigmine—Alzheimer's disease	0.000486	0.000973	CcSEcCtD
Salbutamol—Constipation—Rivastigmine—Alzheimer's disease	0.000482	0.000965	CcSEcCtD
Salbutamol—Pain—Rivastigmine—Alzheimer's disease	0.000482	0.000965	CcSEcCtD
Salbutamol—Feeling abnormal—Memantine—Alzheimer's disease	0.000475	0.00095	CcSEcCtD
Salbutamol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000471	0.000943	CcSEcCtD
Salbutamol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000467	0.000936	CcSEcCtD
Salbutamol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000464	0.00093	CcSEcCtD
Salbutamol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000461	0.000923	CcSEcCtD
Salbutamol—Urticaria—Memantine—Alzheimer's disease	0.000458	0.000916	CcSEcCtD
Salbutamol—Abdominal pain—Memantine—Alzheimer's disease	0.000455	0.000912	CcSEcCtD
Salbutamol—Body temperature increased—Memantine—Alzheimer's disease	0.000455	0.000912	CcSEcCtD
Salbutamol—Asthenia—Donepezil—Alzheimer's disease	0.000455	0.000911	CcSEcCtD
Salbutamol—Pruritus—Donepezil—Alzheimer's disease	0.000449	0.000899	CcSEcCtD
Salbutamol—Urticaria—Rivastigmine—Alzheimer's disease	0.000448	0.000896	CcSEcCtD
Salbutamol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000445	0.000892	CcSEcCtD
Salbutamol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000445	0.000892	CcSEcCtD
Salbutamol—Diarrhoea—Donepezil—Alzheimer's disease	0.000434	0.000869	CcSEcCtD
Salbutamol—Hypersensitivity—Memantine—Alzheimer's disease	0.000424	0.00085	CcSEcCtD
Salbutamol—Dizziness—Donepezil—Alzheimer's disease	0.000419	0.00084	CcSEcCtD
Salbutamol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000415	0.000831	CcSEcCtD
Salbutamol—Asthenia—Memantine—Alzheimer's disease	0.000413	0.000828	CcSEcCtD
Salbutamol—Pruritus—Memantine—Alzheimer's disease	0.000408	0.000816	CcSEcCtD
Salbutamol—Asthenia—Rivastigmine—Alzheimer's disease	0.000404	0.00081	CcSEcCtD
Salbutamol—Vomiting—Donepezil—Alzheimer's disease	0.000403	0.000808	CcSEcCtD
Salbutamol—Rash—Donepezil—Alzheimer's disease	0.0004	0.000801	CcSEcCtD
Salbutamol—Dermatitis—Donepezil—Alzheimer's disease	0.0004	0.0008	CcSEcCtD
Salbutamol—Pruritus—Rivastigmine—Alzheimer's disease	0.000399	0.000798	CcSEcCtD
Salbutamol—Headache—Donepezil—Alzheimer's disease	0.000397	0.000796	CcSEcCtD
Salbutamol—Diarrhoea—Memantine—Alzheimer's disease	0.000394	0.000789	CcSEcCtD
Salbutamol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000386	0.000772	CcSEcCtD
Salbutamol—Dizziness—Memantine—Alzheimer's disease	0.000381	0.000763	CcSEcCtD
Salbutamol—Nausea—Donepezil—Alzheimer's disease	0.000377	0.000755	CcSEcCtD
Salbutamol—Dizziness—Rivastigmine—Alzheimer's disease	0.000373	0.000746	CcSEcCtD
Salbutamol—Vomiting—Memantine—Alzheimer's disease	0.000366	0.000733	CcSEcCtD
Salbutamol—Rash—Memantine—Alzheimer's disease	0.000363	0.000727	CcSEcCtD
Salbutamol—Dermatitis—Memantine—Alzheimer's disease	0.000363	0.000727	CcSEcCtD
Salbutamol—Headache—Memantine—Alzheimer's disease	0.000361	0.000723	CcSEcCtD
Salbutamol—Vomiting—Rivastigmine—Alzheimer's disease	0.000358	0.000717	CcSEcCtD
Salbutamol—Rash—Rivastigmine—Alzheimer's disease	0.000355	0.000711	CcSEcCtD
Salbutamol—Dermatitis—Rivastigmine—Alzheimer's disease	0.000355	0.000711	CcSEcCtD
Salbutamol—Headache—Rivastigmine—Alzheimer's disease	0.000353	0.000707	CcSEcCtD
Salbutamol—Nausea—Memantine—Alzheimer's disease	0.000342	0.000685	CcSEcCtD
Salbutamol—Nausea—Rivastigmine—Alzheimer's disease	0.000335	0.00067	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—IAPP—Alzheimer's disease	0.000101	0.00253	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CRH—Alzheimer's disease	0.000101	0.00251	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CRH—Alzheimer's disease	9.84e-05	0.00246	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PYY—Alzheimer's disease	9.83e-05	0.00246	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PYY—Alzheimer's disease	9.61e-05	0.0024	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—NPS—Alzheimer's disease	9.54e-05	0.00238	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—NPS—Alzheimer's disease	9.33e-05	0.00233	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—SST—Alzheimer's disease	9.1e-05	0.00227	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR6—Alzheimer's disease	9.03e-05	0.00226	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	8.99e-05	0.00224	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—SST—Alzheimer's disease	8.9e-05	0.00222	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—APP—Alzheimer's disease	8.87e-05	0.00221	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR6—Alzheimer's disease	8.84e-05	0.00221	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	8.79e-05	0.0022	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	8.79e-05	0.0022	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—APP—Alzheimer's disease	8.67e-05	0.00217	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	8.6e-05	0.00215	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	8.55e-05	0.00213	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CDK5—Alzheimer's disease	8.52e-05	0.00213	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CDK5—Alzheimer's disease	8.34e-05	0.00208	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR6—Alzheimer's disease	8.2e-05	0.00205	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR6—Alzheimer's disease	8.02e-05	0.002	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	7.7e-05	0.00192	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	7.53e-05	0.00188	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	7.53e-05	0.00188	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—GAL—Alzheimer's disease	7.5e-05	0.00187	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	7.37e-05	0.00184	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—GAL—Alzheimer's disease	7.34e-05	0.00183	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—GAL—Alzheimer's disease	6.81e-05	0.0017	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—GAL—Alzheimer's disease	6.66e-05	0.00166	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TTR—Alzheimer's disease	6.64e-05	0.00166	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	6.61e-05	0.00165	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TTR—Alzheimer's disease	6.5e-05	0.00162	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	6.48e-05	0.00162	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	6.46e-05	0.00161	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	6.35e-05	0.00159	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	6.26e-05	0.00156	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—NPY—Alzheimer's disease	5.89e-05	0.00147	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	5.89e-05	0.00147	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CCR5—Alzheimer's disease	5.86e-05	0.00146	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—IAPP—Alzheimer's disease	5.86e-05	0.00146	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PYY—Alzheimer's disease	5.81e-05	0.00145	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—NPY—Alzheimer's disease	5.76e-05	0.00144	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	5.76e-05	0.00144	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR2A—Alzheimer's disease	5.74e-05	0.00143	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCR5—Alzheimer's disease	5.74e-05	0.00143	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—IAPP—Alzheimer's disease	5.73e-05	0.00143	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CRH—Alzheimer's disease	5.69e-05	0.00142	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PYY—Alzheimer's disease	5.68e-05	0.00142	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR2A—Alzheimer's disease	5.61e-05	0.0014	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CRH—Alzheimer's disease	5.56e-05	0.00139	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—NPS—Alzheimer's disease	5.39e-05	0.00135	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—NPY—Alzheimer's disease	5.35e-05	0.00134	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IAPP—Alzheimer's disease	5.32e-05	0.00133	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—NPS—Alzheimer's disease	5.27e-05	0.00132	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NPY—Alzheimer's disease	5.23e-05	0.00131	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IAPP—Alzheimer's disease	5.2e-05	0.0013	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CRH—Alzheimer's disease	5.16e-05	0.00129	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—SST—Alzheimer's disease	5.14e-05	0.00128	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—GAB2—Alzheimer's disease	5.14e-05	0.00128	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CRH—Alzheimer's disease	5.05e-05	0.00126	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CDK5—Alzheimer's disease	5.03e-05	0.00126	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	5.03e-05	0.00126	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	5.03e-05	0.00126	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	5.03e-05	0.00126	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	5.01e-05	0.00125	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	4.92e-05	0.00123	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	4.92e-05	0.00123	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	4.9e-05	0.00122	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	4.89e-05	0.00122	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	4.87e-05	0.00122	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	4.85e-05	0.00121	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	4.79e-05	0.0012	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	4.76e-05	0.00119	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	4.74e-05	0.00118	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	4.73e-05	0.00118	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	4.67e-05	0.00117	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	4.67e-05	0.00117	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	4.63e-05	0.00116	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	4.57e-05	0.00114	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	4.57e-05	0.00114	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	4.55e-05	0.00114	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	4.48e-05	0.00112	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	4.45e-05	0.00111	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	4.4e-05	0.0011	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	4.39e-05	0.0011	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	4.34e-05	0.00108	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	4.3e-05	0.00108	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	4.29e-05	0.00107	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	4.24e-05	0.00106	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	4.22e-05	0.00106	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	4.2e-05	0.00105	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	4.13e-05	0.00103	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	4.12e-05	0.00103	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	4.03e-05	0.00101	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	4.02e-05	0.00101	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	4.02e-05	0.00101	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	3.94e-05	0.000983	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	3.94e-05	0.000983	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.67e-05	0.000917	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	3.55e-05	0.000886	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.5e-05	0.000873	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	3.47e-05	0.000867	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	3.44e-05	0.000858	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	3.42e-05	0.000854	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	3.36e-05	0.000839	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	3.31e-05	0.000828	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	3.24e-05	0.00081	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	3.24e-05	0.00081	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	3.18e-05	0.000793	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	3.17e-05	0.000792	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	3.16e-05	0.00079	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	3.14e-05	0.000785	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.12e-05	0.00078	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	3.11e-05	0.000776	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	3.09e-05	0.000773	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	3.07e-05	0.000768	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	3.05e-05	0.000762	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	3.01e-05	0.000752	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	2.98e-05	0.000745	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	2.94e-05	0.000736	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	2.94e-05	0.000735	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.93e-05	0.000733	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	2.89e-05	0.000722	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	2.88e-05	0.00072	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	2.88e-05	0.000719	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	2.84e-05	0.00071	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	2.84e-05	0.000708	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	2.83e-05	0.000707	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	2.81e-05	0.000703	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.78e-05	0.000695	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	2.78e-05	0.000695	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	2.77e-05	0.000693	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	2.76e-05	0.000689	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	2.76e-05	0.000689	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	2.76e-05	0.000689	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	2.75e-05	0.000686	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	2.73e-05	0.000683	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	2.7e-05	0.000674	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	2.7e-05	0.000674	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	2.7e-05	0.000674	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	2.69e-05	0.000671	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	2.69e-05	0.000671	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	2.67e-05	0.000668	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.65e-05	0.000663	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	2.63e-05	0.000657	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	2.58e-05	0.000645	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.54e-05	0.000636	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	2.54e-05	0.000634	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	2.53e-05	0.000631	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	2.48e-05	0.00062	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.45e-05	0.000612	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	2.37e-05	0.000591	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.37e-05	0.000591	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	2.35e-05	0.000587	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	2.31e-05	0.000578	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	2.31e-05	0.000577	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	2.3e-05	0.000575	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	2.3e-05	0.000575	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	2.26e-05	0.000565	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	2.25e-05	0.000562	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	2.19e-05	0.000546	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	2.14e-05	0.000534	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	2.08e-05	0.00052	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	2.04e-05	0.000509	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	2.01e-05	0.000503	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	1.97e-05	0.000492	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	1.93e-05	0.000482	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	1.91e-05	0.000478	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	1.89e-05	0.000471	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	1.88e-05	0.000469	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	1.87e-05	0.000467	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	1.83e-05	0.000458	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	1.83e-05	0.000456	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	1.79e-05	0.000446	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	1.78e-05	0.000444	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	1.74e-05	0.000435	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	1.74e-05	0.000434	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	1.7e-05	0.000425	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	1.62e-05	0.000405	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	1.62e-05	0.000404	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	1.62e-05	0.000404	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	1.6e-05	0.0004	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	1.59e-05	0.000397	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	1.58e-05	0.000395	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	1.58e-05	0.000395	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	1.57e-05	0.000392	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	1.54e-05	0.000386	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	1.52e-05	0.000381	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.52e-05	0.000381	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.52e-05	0.000381	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	1.51e-05	0.000377	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.49e-05	0.000373	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	1.49e-05	0.000373	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.46e-05	0.000365	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	1.46e-05	0.000365	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.41e-05	0.000351	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	1.4e-05	0.00035	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	1.39e-05	0.000347	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	1.38e-05	0.000345	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	1.37e-05	0.000342	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	1.36e-05	0.00034	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	1.36e-05	0.000339	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.36e-05	0.000339	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	1.35e-05	0.000338	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	1.34e-05	0.000334	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	1.33e-05	0.000332	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	1.31e-05	0.000327	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	1.21e-05	0.000303	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	1.19e-05	0.000296	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.18e-05	0.000295	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.17e-05	0.000292	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.11e-05	0.000277	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.11e-05	0.000277	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.09e-05	0.000271	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.04e-05	0.000259	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.03e-05	0.000257	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	1.03e-05	0.000257	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	1.02e-05	0.000255	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.02e-05	0.000254	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	1.01e-05	0.000251	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	1e-05	0.00025	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	9.72e-06	0.000243	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	9.45e-06	0.000236	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	9.43e-06	0.000235	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	9.42e-06	0.000235	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	9.25e-06	0.000231	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	9.22e-06	0.00023	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	8.73e-06	0.000218	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	8.54e-06	0.000213	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	8.12e-06	0.000203	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	8.08e-06	0.000202	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	8.01e-06	0.0002	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	7.84e-06	0.000196	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LPL—Alzheimer's disease	7.39e-06	0.000185	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	6.65e-06	0.000166	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	6.59e-06	0.000165	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	6.45e-06	0.000161	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CALM1—Alzheimer's disease	6.22e-06	0.000155	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—APOE—Alzheimer's disease	6.19e-06	0.000155	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CAV1—Alzheimer's disease	6.14e-06	0.000153	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	6.04e-06	0.000151	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	5.9e-06	0.000148	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	5.57e-06	0.000139	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	5.45e-06	0.000136	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARG—Alzheimer's disease	5.4e-06	0.000135	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—INS—Alzheimer's disease	5.29e-06	0.000132	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NOS3—Alzheimer's disease	4.64e-06	0.000116	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	4.24e-06	0.000106	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.13e-06	5.33e-05	CbGpPWpGaD
